Compare DAL & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAL | RMD |
|---|---|---|
| Founded | 1924 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.2B | 36.4B |
| IPO Year | N/A | 1995 |
| Metric | DAL | RMD |
|---|---|---|
| Price | $67.30 | $256.54 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | $74.00 | ★ $292.27 |
| AVG Volume (30 Days) | ★ 7.5M | 979.4K |
| Earning Date | 01-09-2026 | 10-30-2025 |
| Dividend Yield | ★ 1.12% | 0.94% |
| EPS Growth | N/A | ★ 29.59 |
| EPS | 7.09 | ★ 9.77 |
| Revenue | ★ $62,920,000,000.00 | $5,257,400,000.00 |
| Revenue This Year | N/A | $9.81 |
| Revenue Next Year | $5.80 | $7.31 |
| P/E Ratio | ★ $9.46 | $26.26 |
| Revenue Growth | 4.33 | ★ 9.36 |
| 52 Week Low | $34.74 | $199.92 |
| 52 Week High | $69.98 | $293.81 |
| Indicator | DAL | RMD |
|---|---|---|
| Relative Strength Index (RSI) | 67.75 | 54.75 |
| Support Level | $63.00 | $237.63 |
| Resistance Level | $68.06 | $254.10 |
| Average True Range (ATR) | 2.12 | 5.28 |
| MACD | 0.91 | 1.28 |
| Stochastic Oscillator | 93.20 | 92.08 |
Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke network, where it gathers and distributes passengers across the globe through its biggest hubs in Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta has historically earned most of its international revenue and profits from flying passengers over the Atlantic Ocean.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.